NCT07476495 Insights on Dissemination of Lung Cancer
| NCT ID | NCT07476495 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Oncology & Epidemiology & Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2029-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-02-01 with a primary completion date of 2029-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In patients with resectable NSCLC treated with surgery alone or with surgery as part of a multimodal treatment; CTC, ctDNA, STAS, and lymph node micrometastasis levels will be evaluated to see if they are associated with recurrence patterns and long-term outcomes.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years; * Preoperative diagnosis of resectable stage cIA-cIIIA NSCLC (adenocarcinoma or squamous cell carcinoma); * Patients deemed fit for surgical or multimodal treatment; * Informed consent obtained; * Treatment, including multimodal treatment, involving surgery. Exclusion Criteria: * Histology other than adenocarcinoma or squamous cell carcinoma; * Other neoplastic diseases concurrent with or undergoing treatment or treated with systemic therapies in the previous three years; * Age \<18 years; * No need for surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07476495 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Oncology & Epidemiology & Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07476495 currently recruiting?
Yes, NCT07476495 is actively recruiting participants. Contact the research team at pietro.bertoglio@aosp.bo.it for enrollment information.
Where is the NCT07476495 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT07476495 clinical trial?
NCT07476495 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 100 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.